32 results on '"Grigoletto, Jessica"'
Search Results
2. Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein
3. Oral and intravenous transmission of α-synuclein fibrils to mice
4. A role for α-Synuclein in axon growth and its implications in corticostriatal glutamatergic plasticity in Parkinson’s disease
5. The 5-HT4 receptor agonist, Velusetrag, rescues GI dysfunction, gut inflammation and dysbiosis in the A53T αS mouse model of Parkinson’s Disease.
6. Long-term decrease in Na+,K+-ATPase activity after pilocarpine-induced status epilepticus is associated with nitration of its alpha subunit
7. Alpha-Synuclein and Parkinson’s Disease Motor and Non-Motor Symptoms: What Is New?
8. Additional file 4 of Ischemic stroke causes Parkinson���s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein
9. Additional file 1 of Ischemic stroke causes Parkinson���s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein
10. Additional file 3 of Ischemic stroke causes Parkinson���s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein
11. Additional file 2 of Ischemic stroke causes Parkinson���s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein
12. Loss of Corticostriatal Mu-Opioid Receptors in α-Synuclein Transgenic Mouse Brains
13. Additional file 2 of A role for α-Synuclein in axon growth and its implications in corticostriatal glutamatergic plasticity in Parkinson’s disease
14. Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate
15. Ciliary neurotrophic factor infused intracerebroventricularly shows reduced catabolic effects when linked to the TAT protein transduction domain
16. α‐Synuclein in blood cells differentiates Parkinson’s disease from healthy controls
17. Depletion of Progranulin Reduces GluN2B-Containing NMDA Receptor Density, Tau Phosphorylation, and Dendritic Arborization in Mouse Primary Cortical Neurons
18. Higher levels of myelin phospholipids in brains of neuronal α-Synuclein transgenic mice precede myelin loss
19. Synapsin III alterations in Parkinson's disease
20. Role of dopamine D3R and acetylcholine nicotinic receptor interaction in the regulation of dopaminergic neurons function
21. Role of dopamine D3R/nAChR heterodimeric complex in the regulation of dopaminergic neurons function
22. Analysis in vitro of the neuroprotective action of recombinant human TAT-parkin and parkin over-expression in the 6-hydroxydopamine model of Parkinson's disease
23. α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons
24. Proteomic study of 6-OHDA-induced neurodegeneration of rat nigrostriatal pathway
25. Lysine residues at the first and second KTKEGV repeats mediate α-Synuclein binding to membrane phospholipids
26. The regulation of catalase activity by PPAR γ is affected by α ‐synuclein
27. From α-synuclein to synaptic dysfunctions: New insights into the pathophysiology of Parkinson's disease
28. α-Synuclein- and MPTP-Generated Rodent Models of Parkinsons Disease and the Study of Extracellular Striatal Dopamine Dynamics: A Microdialysis Approach
29. A proteomic approach in the study of an animal model of Parkinson's disease
30. Additional file 1 of A role for α-Synuclein in axon growth and its implications in corticostriatal glutamatergic plasticity in Parkinson’s disease
31. Additional file 1 of A role for α-Synuclein in axon growth and its implications in corticostriatal glutamatergic plasticity in Parkinson’s disease
32. alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.